|
|||||
|
|
Letter: should anti‐viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? |
|
| Authors: | C.‐Y. Zhang Z.‐H. He B.‐K. Ahir C.‐P. Luo N.‐F. Peng L.‐Q. Li |
| Affiliation: | 1. Experimental Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;2. Department of Hepatobiliary Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China;3. Section of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA;4. Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China |
| Abstract: | |
| Keywords: | |